Buruli ulcer

Technical groups

WHO Technical Advisory Group (TAG) on Buruli ulcer

The WHO Technical Advisory Group on Buruli ulcer meets once a year and is composed of 16 members who are chosen for their expertise in Buruli ulcer control and research. Members serve for a period of 3 years and may be reappointed. TAG members are expected to:

  • monitor the implementation of the intensified control strategy;
  • promote research according to agreed priorities;
  • identify obstacles for the effective control of Buruli ulcer and recommend corrective actions;
  • advise on and prioritize new research initiatives;
  • ensure impartial review of new research proposals;
  • promote awareness of Buruli ulcer in the context of neglected tropical diseases;
  • assist in identifying funding to support the implementation of the above-mentioned activities.

Final report of the Technical Advisory Group (TAG) on Buruli ulcer, 2009.

Working Groups

During the Annual Meeting on Buruli ulcer disease which took place at WHO headquarters in Geneva, Switzerland from 22–24 March 2010, 6 WHO Working Groups were established.

The main aim is to accelerate the implementation of the 2009 Cotonou Declaration on Buruli ulcer disease.

The Working Groups are also expected to create conditions for the promotion of international cooperation to tackle the problems associated with Buruli ulcer disease.

The 6 Working Groups are:

  • Strategy implementation and coordination
  • Care and support
  • Laboratory support network
  • Drug treatment
  • Epidemiology and surveillance
  • Research

Buruli in the news!

31 July 2014 | Geneva
Simple test promises early diagnosis of debilitating skin disease

10 July 2014 | Geneva
Clinical epidemiology of laboratory-confi rmed Buruli ulcer in Benin: a cohort
The Lancet , Vol 2 July 2014

20 June 2014 | Geneva
Management of BU–HIV co-infection
Tropical Medicine & International Health, DOI: 10.1111/tmi.12342

18 June 2014 | Geneva
Good data collection is essential for a better understanding of Buruli ulcer
The Lancet Global health, Vol 2, Issue 7

02 January 2014 | Geneva
Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of Mycobacterium ulcerans Disease.
PloSntds DOI: 10.1371/journal.pntd.0002618


Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)